Recombinant Hepatitis B vaccine(Hansenula Polymorpha,CpG and aluminum adjuvants) (Huapu Shijiazhuang Pharma)
重组乙型肝炎疫苗（汉逊酵母，CpG和铝佐剂）（华普石家庄医药）
Report date: 2026/04/15 20:02:38
Base Information
Drug NameRecombinant Hepatitis B vaccine(Hansenula Polymorpha,CpG and aluminum adjuvants) (Huapu Shijiazhuang Pharma)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHuapu Shijiazhuang Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A